Clinical Research Directory

Inclusion Criteria: 1. Age ≥18 years. 2. Symptomatic internal hemorrhoidal disease. 3. Goligher grade II or III hemorrhoids. 4. Predominant hemorrhoidal bleeding (\>or equal 2 episodes of rectal bleeding/ week in last 4 weeks) and/or prolapse. 5. Persistent symptoms despite 4 to 6 weeks of conservative treatment (high fibers diet 25/30 g/day, increase water intake, avoid straining, stool softening and topical treatment as anesthetics and corticosteroids containing preparations) . 6. Suitable for outpatient Polidocanol foam sclerotherapy treatment. 7. Willingness to comply with the study protocol. Exclusion Criteria: 1. Goligher grade IV hemorrhoids. 2. Predominantly external hemorrhoidal disease. 3. Acute thrombosed hemorrhoids. 4. Active anorectal infection. 5. Anal fissure or fistula responsible for presenting symptoms. 6. Known colorectal malignancy. 7. Active inflammatory bowel disease involving the anorectal region. 8. Uncorrected bleeding disorder. 9. Known hypersensitivity to polidocanol. 10. Previous hemorrhoidal surgery substantially altering anorectal anatomy. 11. Severe uncontrolled systemic illness preventing the procedure. 12. Pregnancy where treatment is considered inappropriate according to institutional policy. 13. Inability to provide informed consent. 14. Inability to complete follow-up. \-